Basal Cell Carcinoma Clinical Trials 2023

What are the top hospitals conducting basal cell carcinoma research?

When it comes to advancing research and treatments for basal cell carcinoma, several leading hospitals are at the forefront of innovation. In Duarte, California, the City of Hope Comprehensive Cancer Center is making significant strides with 18 active clinical trials dedicated to this type of skin cancer. Although they have only recorded two all-time trials since their first in 2013, their commitment to finding new solutions is evident. Similarly, the University of California Davis Comprehensive Cancer Center in Sacramento has also embarked on 18 active basal cell carcinoma trials. With three all-time studies conducted since their initial trial in 2013, they are actively contributing to our understanding and management of this condition.

Houston's M D Anderson Cancer Center is another notable institution that has been instrumental in driving progress against basal cell carcinoma. They currently have an impressive number of 18 ongoing clinical trials for this condition and have completed three all-time trials after recording their first trial back in 2007.

In Burbank, California, Providence Saint Joseph Medical Center/Disney Family Cancer Center is focused on combating basal cell carcinoma through cutting-edge research with a remarkable count of seventeen active clinical trials. Despite having conducted just one previous study since commencing its inaugural trial in 2017, they continue to be a vital part of the fight against this form of skin cancer.

Lastly but not least important, USC / Norris Comprehensive Cancer Center located in Los Angeles joins this group with its dedication towards treating basal cell carcinoma by conducting sixteen current clinical tests while adding value by carrying out previous two experiments from starting it's pioneering investigation on such cases way back until1993- ensuring patients benefit from contemporary advancements made within recent years.

These esteemed hospitals are paving the way for improved outcomes and enhanced care options for those affected by basal cell carcinoma. Through relentless research efforts and collaborative initiatives across multiple locations nationwide as mentioned above; medical professionals continue striving towards better understanding & effective treatment strategies ultimately bringing hope into lives confronted by cancers.

Which are the best cities for basal cell carcinoma clinical trials?

When it comes to basal cell carcinoma clinical trials, several cities have emerged as leading hubs for research and development. Anchorage, Alaska takes the lead with an impressive 75 active trials exploring treatments like Bevacizumab, Tamoxifen Citrate, and Arm III (anastrozole and fulvestrant). Oakland, California closely follows with 74 ongoing studies focused on innovative approaches such as Bevacizumab, Trastuzumab, and Paclitaxel. Denver, Colorado is another prominent city in this field with 73 active trials investigating therapeutic options like Bevacizumab, Paclitaxel, and Therapeutic Conventional Surgery. These cities offer individuals facing basal cell carcinoma access to cutting-edge clinical trials that hold promise for improved treatment outcomes.

Which are the top treatments for basal cell carcinoma being explored in clinical trials?

Clinical trials for basal cell carcinoma are actively exploring various treatment options, with one standout contender being bevacizumab. This powerful drug is currently involved in seven active trials dedicated to combating this particular type of skin cancer. With its first listing in 2009, bevacizumab has already shown promise and potential as a potential game-changer in the fight against basal cell carcinoma. Researchers are diligently working towards uncovering new insights and breakthroughs that could revolutionize treatment approaches for patients facing this condition.

What are the most recent clinical trials for basal cell carcinoma?

Exciting advancements are being made in the field of basal cell carcinoma through recent clinical trials. One such trial is investigating the potential benefits of nicotinamide, a form of vitamin B3, for treating basal cell carcinoma. This Phase 3 trial became available on 8/28/2023 and holds promise for improving outcomes for patients with this type of skin cancer. Another trial worth noting is studying CX-4945 as a treatment option for basal cell carcinoma, which entered Phase 1 on 4/1/2019. These trials highlight the ongoing efforts to develop more effective treatments and enhance patient care in the fight against basal cell carcinoma

What basal cell carcinoma clinical trials were recently completed?

In the realm of basal cell carcinoma, several noteworthy clinical trials have recently concluded, showcasing promising developments in treatment options. Morphogenesis, Inc.'s trial investigating IFx-Hu2.0 reached completion in June 2021, providing valuable insights into its potential efficacy against this form of skin cancer. Similarly, Xencor, Inc.'s trial for XmAb20717 wrapped up in July 2018 and Regeneron Pharmaceuticals' study on cemiplimab was finalized back in June 2017. These significant milestones highlight the ongoing dedication to advancing therapeutic strategies for basal cell carcinoma patients and renew hope for improved outcomes.